Inspire Medical Systems (INSP) Asset Writedowns and Impairment (2023 - 2026)

Inspire Medical Systems (INSP) has 4 years of Asset Writedowns and Impairment data on file, last reported at $548000.0 in Q1 2026.

• For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 7.03% year-over-year to $548000.0; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (up 894.34% YoY), and the FY2025 full-year result was $2.1 million, changed N/A from the prior year.
• Asset Writedowns and Impairment advanced to $548000.0 in Q1 2026, from $543000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $4.0 million in Q2 2025 to a low of -$1.3 million in Q4 2023.
• A 4-year average of $810666.7 and a median of $531000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
• Across the five-year window, Asset Writedowns and Impairment declined 1.35% in 2025 and rose 7.03% in 2026, its largest moves.
• Tracing INSP's Asset Writedowns and Impairment over 4 years: stood at -$1.3 million in 2023, then soared by 141.26% to $519000.0 in 2024, then increased by 4.62% to $543000.0 in 2025, then gained by 0.92% to $548000.0 in 2026.
• Business Quant data shows INSP's Asset Writedowns and Impairment at $548000.0 in Q1 2026, $543000.0 in Q4 2025, and $4.0 million in Q2 2025.